Recursion Pharmaceuticals amends Tempus master agreement, SEC filing
Recursion Pharmaceuticals entered an amendment to its master agreement with Tempus, disclosed via an SEC filing dated Sept 15, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.